Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Overview of attention for article published in Drug Design, Development and Therapy, April 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,360 followers.

ICYMI: New article by Dr Raimar Löbenberg Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models https://t.co/ANqHyifAZQ @UAlberta_Pharm

03 Jan 2018

Reply Repost Favourite

New article by Dr Löbenberg Justification of disintegration testing beyond current FDA criteria... https://t.co/ANqHyixcoq @UAlberta_Pharm

16 May 2017

Reply Repost Favourite

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models - Dove… https://t.co/c1wX7ZwUaj

12 Apr 2017

Reply Repost Favourite

Dove Medical Press

Article Metrics

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

About this Attention Score

Mentioned by

Citations

Readers on